EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Endoscopic Papillary Balloon Dilation Can Be Safely Performed in Patients on Dual Antiplatelet Therapy: A Pilot Study

Sakue Masuda, Ryuhei Jinushi, Kazuya Koizumi, Makomo Makazu, Takashi Nishino, Kento Shionoya, Karen Kimura, Chihiro Sumida, Jun Kubota, Chikamasa Ichita, Akiko Sasaki, Masahiro Kobayashi und 3 weitere

Journal of Gastrointestinal and Liver Diseases · 22.06.2023 · 32 (2) · 216-221

DOI: 10.15403/jgld-4764 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 22.06.2023. Verfasst von Sakue Masuda und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shonan Kamakura General Hospital, Kanagawa, Japan. sakue.masuda@tokushukai.jp. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Cholangiopancreatography, Endoscopic Retrograde. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Endoscopic papillary balloon dilation (EPBD), a low-risk procedure for bleeding, hasbeen suggested as an alternative to endoscopic sphincterotomy for papillary dilatation in patients undergoingendoscopic stone removal who are at a higher risk of bleeding. Several guidelines recommend that combinationof two antiplatelet agents should be reduced to single antiplatelet therapy when endoscopic sphincterotomyis performed. However, there is no evidence that EPBD affects the risk of bleeding in patients receiving acombination of two antiplatelet agents; thus, we aimed to explore this problem.

Methods

We included 31 patients who underwent EPBD for common bile duct stones at our hospital fromMay 2014 to August 2022 and received either a combination of two antiplatelet agents or single antiplatelettherapy prior to the procedure. The group receiving a combination of two antiplatelet agents included patientswho underwent EPBT without antiplatelet therapy withdrawal or with a shorter withdrawal period than thoserecommended by the guidelines.

Results

In the group that received a combination of two antiplatelet agents, one of the two antiplateletagents used was thienopyridine. No bleeding was observed after EPBD in this study. We did not findany significant between-group differences in hemoglobin levels and rate of post-endoscopic retrogradecholangiopancreatography pancreatitis.

Conclusions

In patients treated with a combination of two antiplatelet agents, EPBD could be safely performedwithout bleeding. Therefore, future prospective studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsCholangiopancreatography, Endoscopic RetrogradeHumansDilatationPilot ProjectsCatheterizationSphincterotomy, EndoscopicTreatment Outcome

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Shonan Kamakura General Hospital, Kanagawa, Japan. sakue.masuda@tokushukai.jp.
  • Department of Gastroenterology, Shonan Kamakura General Hospital, Kanagawa, Japan. gk3273@icloud.com.
  • Department of Gastroenterology, Shonan Kamakura General Hospital, Kanagawa, Japan. kizm2010@gmail.com.
  • Department of Gastroenterology, Shonan Kamakura General Hospital, Kanagawa, Japan. gonmarota@gmail.com.
  • Department of Gastroenterology, Shonan Kamakura General Hospital, Kanagawa, Japan. tkshnshn8@gmail.com.
  • Department of Gastroenterology, Shonan Kamakura General Hospital, Kanagawa, Japan. kentosh0812@gmail.com.

Zitieren

APA

Masuda, S., Jinushi, R., Koizumi, K., Makazu, M., Nishino, T., Shionoya, K., Kimura, K., Sumida, C., Kubota, J., Ichita, C., Sasaki, A., Kobayashi, M., Kako, M., Uojima, H., & Sugitani, A. (2023). Endoscopic Papillary Balloon Dilation Can Be Safely Performed in Patients on Dual Antiplatelet Therapy: A Pilot Study. Journal of Gastrointestinal and Liver Diseases, 32(2), 216-221. https://doi.org/10.15403/jgld-4764

Vancouver

Masuda S, Jinushi R, Koizumi K, Makazu M, Nishino T, Shionoya K, et al. Endoscopic Papillary Balloon Dilation Can Be Safely Performed in Patients on Dual Antiplatelet Therapy: A Pilot Study. Journal of Gastrointestinal and Liver Diseases. 2023;32(2):216-221. doi:10.15403/jgld-4764

BibTeX
@article{Masuda2023,
  author = {Masuda, Sakue and Jinushi, Ryuhei and Koizumi, Kazuya and Makazu, Makomo and Nishino, Takashi and Shionoya, Kento and Kimura, Karen and Sumida, Chihiro and Kubota, Jun and Ichita, Chikamasa and Sasaki, Akiko and Kobayashi, Masahiro and Kako, Makoto and Uojima, Haruki and Sugitani, Ayumu},
  title = {Endoscopic Papillary Balloon Dilation Can Be Safely Performed in Patients on Dual Antiplatelet Therapy: A Pilot Study},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2023},
  volume = {32},
  number = {2},
  pages = {216--221},
  doi = {10.15403/jgld-4764}
}
Kostenlos starten →